Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04666909 · ClinicalTrials.gov registry record
Take the Pressure Off, NYC!
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 411
- Enrollment target
NCT04666909: Completed study, sponsored by NYU Langone Health.
NCT04666909 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 411 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04666909 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 411 participants
- Enrollment target
Study Summary
Briefly, a trained barbershop navigator will work with each barbershop to measure blood pressure on each adult customer who agrees, and to provide culturally-targeted education about high blood pressure and its consequences, and motivational interviewing-informed counseling about therapeutic lifestyle changes. For customers found to have high blood pressure, the navigator will also provide referral and navigation to a medical provider and, as appropriate, a local pharmacy.
Primary Outcome
Blood pressure will be measured with FDA approved blood pressure monitor on the first day of the study, 3 months and 6 months after the initial study day.
Interventions
- DIAGNOSTIC_TEST blood pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 411 participants |
| Start Date | 2020-10-10 |
| Est. Completion | 2021-12-31 |
What the finished NCT04666909 record still lists
NCT04666909 is an observational study that tracks outcomes without assigning an intervention. The registered 411 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which blood pressure is the first listed.
NCT04666909 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04666909 about?
NCT04666909 is a clinical study titled "Take the Pressure Off, NYC!". Briefly, a trained barbershop navigator will work with each barbershop to measure blood pressure on each adult customer who agrees, and to provide culturally-targeted education about high blood pressure and its consequences, and motivational interviewing-informed counseling about therapeutic lifesty...
What is the current status of trial NCT04666909?
This trial is currently completed. The enrollment target is 411 participants. The study started on 2020-10-10. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04666909?
The interventions under investigation include: blood pressure (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04666909?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05993689 · 412 participants · NA
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
- NCT06699212 · 412 participants · Phase 3
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI